03:50 PM EST - Cangene Corporation : announced today the extension of an existing contract and the signing of a new contract related to United States Government biodefence programs. The Company continues to leverage its expertise in biodefence contracting to supplement its pipeline-focused strategy in the specialty biopharmaceutical space. Cangene Corporation
shares T.CNJ are trading up $0.14 at $1.59.
